tetano
Editor, Senior Moderator
BMC Ophthalmol
. 2024 Jan 17;24(1):23.
doi: 10.1186/s12886-024-03289-w. New onset or recurrence of uveitis following COVID-19 infection
Hui Feng[SUP] 1 [/SUP], Meng Zhao[SUP] 1 [/SUP], Jing Mo[SUP] 1 [/SUP], Xusheng Cao[SUP] 1 [/SUP], Weixin Chen[SUP] 1 [/SUP], Hong Wang[SUP] 2 [/SUP]
Affiliations
Background: While the 2019 novel coronavirus disease (COVID-19) pandemic has resulted in millions of cases worldwide, there is increasing recognition of a wide range of ocular manifestations associated with the virus, including uveitis. Uveitis is an inflammatory condition of the uveal tract of the eye that can lead to permanent vision loss if not treated promptly. Here we report a retrospective observational study of patients who presented with new onset or recurrent uveitis following COVID-19 infection.
Methods: This is a retrospective observational study conducted at the Beijing Tongren Hospital. We identified patients who presented with symptoms of non-infectious active uveitis with positive real-time reverse transcription polymerase chain reaction (RT-PCR) of COVID-19 within 4 weeks. All patients received ophthalmic examinations, including anterior and posterior segment imaging, to assess the extent of ocular involvement.
Results: The 18 patients with a total of 33 eyes included in this study presented with symptoms of active uveitis within 4 weeks of their positive COVID-19 RT-PCR test. Among them, 9 patients presented with the development of uveitis following COVID-19 infection, and 9 patients had relapsed uveitis after COVID-19 infection. Treatment with corticosteroids resulted in improvement of symptoms and resolution of inflammation in all cases. In this study, all patients did not experience any adverse drug reactions during treatment.
Conclusion: Our observational study highlights the potential for new onset or recurrence of uveitis following COVID-19 infection.
Trial registration: https://www.chictr.org.cn/ ; identifier: ChiCTR2100044365, date: 03/17/2023.
Keywords: COVID-19; New onset uveitis; Uveitis relapse.
. 2024 Jan 17;24(1):23.
doi: 10.1186/s12886-024-03289-w. New onset or recurrence of uveitis following COVID-19 infection
Hui Feng[SUP] 1 [/SUP], Meng Zhao[SUP] 1 [/SUP], Jing Mo[SUP] 1 [/SUP], Xusheng Cao[SUP] 1 [/SUP], Weixin Chen[SUP] 1 [/SUP], Hong Wang[SUP] 2 [/SUP]
Affiliations
- PMID: 38233844
- DOI: 10.1186/s12886-024-03289-w
Background: While the 2019 novel coronavirus disease (COVID-19) pandemic has resulted in millions of cases worldwide, there is increasing recognition of a wide range of ocular manifestations associated with the virus, including uveitis. Uveitis is an inflammatory condition of the uveal tract of the eye that can lead to permanent vision loss if not treated promptly. Here we report a retrospective observational study of patients who presented with new onset or recurrent uveitis following COVID-19 infection.
Methods: This is a retrospective observational study conducted at the Beijing Tongren Hospital. We identified patients who presented with symptoms of non-infectious active uveitis with positive real-time reverse transcription polymerase chain reaction (RT-PCR) of COVID-19 within 4 weeks. All patients received ophthalmic examinations, including anterior and posterior segment imaging, to assess the extent of ocular involvement.
Results: The 18 patients with a total of 33 eyes included in this study presented with symptoms of active uveitis within 4 weeks of their positive COVID-19 RT-PCR test. Among them, 9 patients presented with the development of uveitis following COVID-19 infection, and 9 patients had relapsed uveitis after COVID-19 infection. Treatment with corticosteroids resulted in improvement of symptoms and resolution of inflammation in all cases. In this study, all patients did not experience any adverse drug reactions during treatment.
Conclusion: Our observational study highlights the potential for new onset or recurrence of uveitis following COVID-19 infection.
Trial registration: https://www.chictr.org.cn/ ; identifier: ChiCTR2100044365, date: 03/17/2023.
Keywords: COVID-19; New onset uveitis; Uveitis relapse.